Insider Transactions in Q2 2017 at Thermo Fisher Scientific Inc. (TMO)
Insider Transaction List (Q2 2017)
Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Jun 05
2017
|
Stephen Williamson Sr. VP and CFO |
SELL
Open market or private sale
|
Direct |
2,500
-6.21%
|
$440,000
$176.26 P/Share
|
Jun 01
2017
|
Marc N Casper Chairman & CEO |
SELL
Open market or private sale
|
Direct |
20,000
-6.91%
|
$3,440,000
$172.79 P/Share
|
May 24
2017
|
Daniel P Shine Senior Vice President |
SELL
Open market or private sale
|
Direct |
4,688
-8.38%
|
$801,648
$171.88 P/Share
|
May 24
2017
|
Daniel P Shine Senior Vice President |
BUY
Exercise of conversion of derivative security
|
Direct |
4,688
+13.83%
|
$304,720
$65.15 P/Share
|
May 17
2017
|
Nelson Chai Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,024
+8.8%
|
-
|
May 17
2017
|
C Martin Harris Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,024
+15.29%
|
-
|
May 17
2017
|
Tyler Jacks Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,024
+8.4%
|
-
|
May 17
2017
|
Judy C Lewent Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,024
+5.79%
|
-
|
May 17
2017
|
Thomas J Lynch Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,024
+7.24%
|
-
|
May 17
2017
|
Jim P Manzi Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,024
+2.51%
|
-
|
May 17
2017
|
Lars Rebien Sorensen Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,024
+12.4%
|
-
|
May 17
2017
|
Lars Rebien Sorensen Director |
SELL
Payment of exercise price or tax liability
|
Direct |
300
-4.61%
|
$51,000
$170.97 P/Share
|
May 17
2017
|
Elaine Ullian Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,024
+11.77%
|
-
|
May 17
2017
|
Dion J Weisler Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,024
+50.0%
|
-
|
May 17
2017
|
Scott M Sperling Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,024
+1.23%
|
-
|
May 17
2017
|
William G Parrett Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,024
+6.97%
|
-
|
Apr 27
2017
|
Thomas W Loewald Senior Vice President |
SELL
Open market or private sale
|
Direct |
1,532
-3.58%
|
$257,376
$168.76 P/Share
|